{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:59:47Z","timestamp":1788393587220,"version":"build-2803163510"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004830","name":"Siemens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004830","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"BMBF Bonn","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100025866","name":"American Angus Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["331065168"],"award-info":[{"award-number":["331065168"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["445703531"],"award-info":[{"award-number":["445703531"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jconrel.2025.113815","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T19:15:31Z","timestamp":1746213331000},"page":"113815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Nanoparticles in nuclear medicine: From diagnostics to therapeutics"],"prefix":"10.1016","volume":"383","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Barmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix M.","family":"Mottaghy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kiessling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Twan","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger M.","family":"Pallares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jconrel.2025.113815_bb0005","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1118\/1.3626488","article-title":"Basic sciences of nuclear medicine","volume":"38","author":"Zanzonico","year":"2011","journal-title":"Med. Phys."},{"key":"10.1016\/j.jconrel.2025.113815_bb0010","series-title":"Essentials of Nuclear Medicine Imaging: Expert Consult-Online and Print","author":"Mettler","year":"2012"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113815_bb0015","doi-asserted-by":"crossref","DOI":"10.1118\/1.4811156","article-title":"The essential physics of medical imaging","volume":"40","author":"Mahesh","year":"2013","journal-title":"Med. Phys."},{"key":"10.1016\/j.jconrel.2025.113815_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1020188","article-title":"Development of radiopharmaceuticals for targeted alpha therapy: where do we stand?","volume":"9","author":"Pallares","year":"2022","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113815_bb0025","first-page":"32","article-title":"Targeted alpha and beta radiotherapy: an overview of radiopharmaceutical and clinical aspects","volume":"42","author":"Lacoeuille","year":"2018","journal-title":"M\u00e9d. Nucl."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113815_bb0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41568-022-00496-9","article-title":"Cancer nanomedicine","volume":"22","author":"Bhatia","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113815_bb0035","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.2967\/jnumed.122.263895","article-title":"Nanoparticle diagnostics and theranostics in the clinic","volume":"63","author":"Pallares","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2025.113815_bb0040","first-page":"413","article-title":"Bridging the gap between lab and clinic for nanodiagnostics","author":"Pallares","year":"2023","journal-title":"Future Med."},{"key":"10.1016\/j.jconrel.2025.113815_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.113815_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114115","article-title":"Nanomedicine for brain cancer","volume":"182","author":"Quader","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113815_bb0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s44222-024-00154-9","article-title":"The mechanisms of nanoparticle delivery to solid tumours","volume":"2","author":"Nguyen","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2025.113815_bb0060","first-page":"1","article-title":"Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact","author":"Dasgupta","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"issue":"19","key":"10.1016\/j.jconrel.2025.113815_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300069","article-title":"Advanced nanomedicine: redefining therapeutic paradigms for inflammatory bowel disease","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.113815_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101008","article-title":"Progress, challenges, and future of nanomedicine","volume":"35","author":"Zhang","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.113815_bb0075","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1007\/s12274-020-2957-8","article-title":"Nanoparticles for targeted cancer radiotherapy","volume":"13","author":"Pallares","year":"2020","journal-title":"Nano Res."},{"issue":"11","key":"10.1016\/j.jconrel.2025.113815_bb0080","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","author":"van der Meel","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113815_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113815_bb0090","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","volume":"5","author":"Li","year":"2008","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113815_bb0095","first-page":"233","article-title":"Study of the lymphatics of the mammary gland with radioactive gold 198","volume":"4","author":"Leborgne","year":"1955","journal-title":"Torax"},{"issue":"3","key":"10.1016\/j.jconrel.2025.113815_bb0100","first-page":"22","article-title":"Lymph node scanning and imaging using colloidal 198Au","volume":"1","author":"Drewett","year":"1973","journal-title":"J. Nucl. Med. Technol."},{"key":"10.1016\/j.jconrel.2025.113815_bb0105","series-title":"Seminars in Nuclear Medicine","first-page":"260","article-title":"Evolution of Tc-99m in diagnostic radiopharmaceuticals","author":"Banerjee","year":"2001"},{"key":"10.1016\/j.jconrel.2025.113815_bb0110","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00259-010-1390-8","article-title":"A review on the clinical uses of SPECT\/CT","volume":"37","author":"Mariani","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2025.113815_bb0115","series-title":"Radioguided Surgery: A Comprehensive Team Approach","first-page":"3","article-title":"Radiopharmaceuticals for radioguided surgery","author":"Obenaus","year":"2008"},{"key":"10.1016\/j.jconrel.2025.113815_bb0120","series-title":"Correspondence Continuing Education Courses for Nuclear Pharmacists and Nuclear Medicine Professionals","article-title":"Lymphoscintigraphy and sentinel node biopsy in the staging of cancer","volume":"11","author":"Hinkle","year":"2005"},{"key":"10.1016\/j.jconrel.2025.113815_bb0125","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1007\/s00259-004-1526-9","article-title":"Sentinel node detection in pre-operative axillary staging","volume":"31","author":"Trifir\u00f2","year":"2004","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.jconrel.2025.113815_bb0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00006231-200403000-00004","article-title":"The impact of radiopharmaceutical particle size on the visualization and identification of sentinel nodes in breast cancer","volume":"25","author":"Leidenius","year":"2004","journal-title":"Nucl. Med. Commun."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113815_bb0135","first-page":"1198","article-title":"Radioguided sentinel lymph node biopsy in breast cancer surgery","volume":"42","author":"Mariani","year":"2001","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113815_bb0140","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1148\/rg.263055139","article-title":"Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection","volume":"26","author":"Palestro","year":"2006","journal-title":"Radiographics"},{"issue":"9","key":"10.1016\/j.jconrel.2025.113815_bb0145","first-page":"1471","article-title":"Leukocyte labeling with technetium-99m tin colloids","volume":"28","author":"Mock","year":"1987","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113815_bb0150","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0883-2897(88)90060-8","article-title":"Phagocytic labeling of leukocytes with 99mTc-albumin colloid for nuclear imaging","volume":"15","author":"Marcus","year":"1988","journal-title":"Int. J. Radiat. Appl. Instrum. B Nucl. Med. Biol."},{"key":"10.1016\/j.jconrel.2025.113815_bb0155","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s00259-010-1394-4","article-title":"Guidelines for the labelling of leucocytes with 99m Tc-HMPAO","volume":"37","author":"de Vries","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113815_bb0160","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/028418518903000612","article-title":"Clinical comparison of 99Tcm-HMPAO labelled leucocytes and 99Tcm-nanocolloid in the detection of inflammation","volume":"30","author":"Vorne","year":"1989","journal-title":"Acta Radiol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113815_bb0165","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00259-024-06915-3","article-title":"EANM\/SNMMI guideline\/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0","volume":"52","author":"Abikhzer","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2025.113815_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijscr.2019.08.009","article-title":"Tc-99m sulfur colloid SPECT-CT and assessment of functional liver reserve after Y90 radioembolization: a case report","volume":"62","author":"Chan","year":"2019","journal-title":"Int. J. Surg. Case Rep."},{"key":"10.1016\/j.jconrel.2025.113815_bb0175","series-title":"Esophageal Transit Scintigraphy, Seminars in Nuclear Medicine","first-page":"306","author":"Klein","year":"1995"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113815_bb0180","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/187152611796504827","article-title":"Microaspiration in intubated critically ill patients: diagnosis and prevention","volume":"11","author":"Nseir","year":"2011","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.jconrel.2025.113815_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-017-0430-2","article-title":"Tumor-associated macrophages: from basic research to clinical application","volume":"10","author":"Yang","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"13","key":"10.1016\/j.jconrel.2025.113815_bb0190","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-18-2076","article-title":"Tumor-associated macrophages as prognostic and predictive biomarkers for postoperative adjuvant chemotherapy in patients with stage II colon cancer","volume":"25","author":"Feng","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113815_bb0195","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.1021\/acsnano.8b04338","article-title":"Quantitative imaging of tumor-associated macrophages and their response to therapy using 64Cu-labeled macrin","volume":"12","author":"Kim","year":"2018","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113815_bb0200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiol.2020201791","article-title":"Detecting immune response to therapies targeting PDL1 and BRAF by using ferumoxytol MRI and macrin in anaplastic thyroid cancer","volume":"298","author":"Ng","year":"2021","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.jconrel.2025.113815_bb0205","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.010586","article-title":"Imaging cardiovascular and lung macrophages with the positron emission tomography sensor 64Cu-macrin in mice, rabbits, and pigs","volume":"13","author":"Nahrendorf","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.jconrel.2025.113815_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1331480","article-title":"Host-functionalization of macrin nanoparticles to enable drug loading and control tumor-associated macrophage phenotype","volume":"15","author":"Sarkar","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113815_bb0215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1148\/radiol.14131520","article-title":"Nanoparticles for imaging: top or flop?","volume":"273","author":"Kiessling","year":"2014","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.jconrel.2025.113815_bb0220","article-title":"Toward clinical transfer of tumor-targeted ultrasmall inorganic nanoparticles","volume":"6","author":"Carm\u00e8s","year":"2023","journal-title":"Adv. Ther."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113815_bb0225","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41578-021-00385-x","article-title":"Clinical translation of silica nanoparticles","volume":"6","author":"Janjua","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.113815_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114638","article-title":"Ultrasmall silica nanoparticles in translational biomedical research: overview and outlook","volume":"192","author":"Singh","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113815_bb0235","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1039\/c2ib20174g","article-title":"Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions","volume":"5","author":"Bradbury","year":"2013","journal-title":"Integr. Biol."},{"issue":"47","key":"10.1016\/j.jconrel.2025.113815_bb0240","doi-asserted-by":"crossref","first-page":"43879","DOI":"10.1021\/acsami.9b15195","article-title":"Ultrasmall renally clearable silica nanoparticles target prostate cancer","volume":"11","author":"Chen","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.113815_bb0245","first-page":"1","article-title":"Histopathological biomarkers for predicting the tumour accumulation of nanomedicines","author":"May","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113815_bb0250","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7150\/ntno.20564","article-title":"Prediction of anti-cancer nanotherapy efficacy by imaging","volume":"1","author":"Miller","year":"2017","journal-title":"Nanotheranostics"},{"issue":"11","key":"10.1016\/j.jconrel.2025.113815_bb0255","doi-asserted-by":"crossref","first-page":"16974","DOI":"10.1021\/acsnano.1c09139","article-title":"Nanoparticles for cancer diagnosis, radionuclide therapy and theranostics","volume":"15","author":"Llop","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113815_bb0260","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.biomaterials.2015.02.085","article-title":"Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles","volume":"53","author":"Hu","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113815_bb0265","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jconrel.2016.07.012","article-title":"Tailoring the physicochemical properties of core-crosslinked polymeric micelles for pharmaceutical applications","volume":"244","author":"Hu","year":"2016","journal-title":"J. Control. Release"},{"issue":"21","key":"10.1016\/j.jconrel.2025.113815_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201043","article-title":"PET-CT imaging of polymeric nanoparticle tumor accumulation in patients","volume":"34","author":"Miedema","year":"2022","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113815_bb0275","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2023-004308","article-title":"CINOVA: a phase II study of CPC634 (nanoparticulate docetaxel) in patients with platinum resistant recurrent ovarian cancer","volume":"33","author":"Boere","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jconrel.2025.113815_bb0280","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113815_bb0285","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00432-014-1767-3","article-title":"Cancer active targeting by nanoparticles: a comprehensive review of literature","volume":"141","author":"Bazak","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113815_bb0290","doi-asserted-by":"crossref","first-page":"2312169","DOI":"10.1002\/adma.202312169","article-title":"Nanomedicine tumor targeting","volume":"36","author":"Lammers","year":"2024","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113815_bb0295","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","article-title":"Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress","volume":"161","author":"Lammers","year":"2012","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113815_bb0300","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-15-1518","article-title":"Dual HER2 targeting with trastuzumab and liposomal-encapsulated doxorubicin (MM-302) demonstrates synergistic antitumor activity in breast and gastric cancer","volume":"76","author":"Espelin","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113815_bb0305","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.nano.2014.08.011","article-title":"A gradient-loadable 64Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomography","volume":"11","author":"Lee","year":"2015","journal-title":"Nanomedicine"},{"issue":"15","key":"10.1016\/j.jconrel.2025.113815_bb0310","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1158\/1078-0432.CCR-16-3193","article-title":"64Cu-MM-302 positron emission tomography quantifies variability of enhanced permeability and retention of nanoparticles in relation to treatment response in patients with metastatic breast cancer","volume":"23","author":"Lee","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113815_bb0315","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1631\/jzus.B1400131","article-title":"Therapeutic radionuclides in nuclear medicine: current and future prospects","volume":"15","author":"Yeong","year":"2014","journal-title":"J Zhejiang Univ Sci B"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113815_bb0320","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1016\/S1470-2045(17)30379-0","article-title":"Targeted radionuclide therapy in combined-modality regimens","volume":"18","author":"Gill","year":"2017","journal-title":"Lancet Oncol."},{"issue":"17","key":"10.1016\/j.jconrel.2025.113815_bb0325","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1001\/jama.283.17.2272","article-title":"Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma","volume":"283","author":"Grigsby","year":"2000","journal-title":"Jama"},{"issue":"21","key":"10.1016\/j.jconrel.2025.113815_bb0330","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1158\/1078-0432.CCR-13-1896","article-title":"Radium-223 chloride: extending life in prostate cancer patients by treating bone metastases","volume":"19","author":"Wissing","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113815_bb0335","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2147\/DDDT.S122417","article-title":"Radium 223 dichloride for prostate cancer treatment","author":"Deshayes","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113815_bb0340","first-page":"386","article-title":"Brachytherapy: an overview for clinicians","volume":"69","author":"Chargari","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2025.113815_bb0345","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00259-017-3751-z","article-title":"177 Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer","volume":"44","author":"Br\u00e4uer","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113815_bb0350","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2967\/jnumed.116.178673","article-title":"225Ac-PSMA-617 for PSMA-targeted \u03b1-radiation therapy of metastatic castration-resistant prostate cancer","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"36","key":"10.1016\/j.jconrel.2025.113815_bb0355","doi-asserted-by":"crossref","first-page":"40078","DOI":"10.1021\/acsami.0c11051","article-title":"Engineering mesoporous silica nanoparticles for targeted alpha therapy against breast cancer","volume":"12","author":"Pallares","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.jconrel.2025.113815_bb0360","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","article-title":"The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis","volume":"6","author":"Sellam","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2025.113815_bb0365","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/978-3-030-39457-8_39","article-title":"Radiosynoviorthesis (radiation synovectomy)","author":"M\u00f6dder","year":"2020","journal-title":"Clin. Nucl. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113815_bb0370","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00259-021-05541-7","article-title":"The EANM guideline for radiosynoviorthesis","volume":"49","author":"Kampen","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2025.113815_bb0375","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/1110-161X.163949","article-title":"Radiosynovectomy of ankle joint synovitis in juvenile rheumatoid arthritis treated with rhenium-188 tin colloid and imaging with SPECT\/CT","volume":"42","author":"Kamaleshwaran","year":"2015","journal-title":"Egypt. Rheumatol. Rehabil."},{"key":"10.1016\/j.jconrel.2025.113815_bb0380","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/BF00173494","article-title":"Radiation synovectomy revisited","volume":"20","author":"Deutsch","year":"1993","journal-title":"Eur. J. Nucl. Med."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113815_bb0385","first-page":"351","article-title":"Die lokale Behandlung der rheumatischen Erkrankungen","volume":"33","author":"Fellinger","year":"1952","journal-title":"Wien Z. Inn. Med."},{"issue":"1 suppl","key":"10.1016\/j.jconrel.2025.113815_bb0390","first-page":"48S","article-title":"Radiosynovectomy in rheumatology, orthopedics, and hemophilia","volume":"46","author":"Schneider","year":"2005","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113815_bb0395","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5435\/00124635-200401000-00008","article-title":"Advances in radionuclide therapeutics in orthopaedics","volume":"12","author":"Siegel","year":"2004","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"10.1016\/j.jconrel.2025.113815_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2019.01.002","article-title":"Radiosynovectomy in haemophilia","volume":"35","author":"Rodriguez-Merchan","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.jconrel.2025.113815_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-014-0481-5","article-title":"Intracranial cystic lesions: a review","volume":"14","author":"Taillibert","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jconrel.2025.113815_bb0410","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11102-012-0418-4","article-title":"Pathology and pathogenesis of craniopharyngiomas","volume":"16","author":"Larkin","year":"2013","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113815_bb0415","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3171\/jns.1980.52.1.0036","article-title":"Management of the unresectable cystic craniopharyngioma by aspiration through an Ommaya reservoir drainage system","volume":"52","author":"Gutin","year":"1980","journal-title":"J. Neurosurg."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113815_bb0420","first-page":"169","article-title":"Stereotaxic treatment of expanding cysts in craniopharyngiomas by endocavitary beta-irradiation (Re-186; Au-198; Y-90)","volume":"31","author":"Musolino","year":"1985","journal-title":"Neuro-chirurgie"},{"issue":"05","key":"10.1016\/j.jconrel.2025.113815_bb0425","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0033-1341413","article-title":"Treatment of cystic craniopharyngioma by endocavitary instillation of yttrium90 radioisotope\u2014still a valuable treatment option","volume":"74","author":"Vanhauwaert","year":"2013","journal-title":"J. Neurol. Surg. A Cent. Eur. Neurosurg."},{"key":"10.1016\/j.jconrel.2025.113815_bb0430","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s00259-013-2451-6","article-title":"Patient-specific dosimetry for intracavitary 32 P-chromic phosphate colloid therapy of cystic brain tumours","volume":"40","author":"Denis-Bacelar","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2025.113815_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.650098","article-title":"Peritoneal metastases from colorectal cancer: defining and addressing the challenges","volume":"11","author":"Kranenburg","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113815_bb0440","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2025.113815_bb0445","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113815_bb0450","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113815_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1165747","article-title":"Targeted alpha particle therapy in oncology","author":"Bruland","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.jconrel.2025.113815_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1070362","article-title":"First experience with 224Radium-labeled microparticles (Radspherin\u00ae) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)","volume":"10","author":"Larsen","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.jconrel.2025.113815_bb0465","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/pharmaceutics13050634","article-title":"Improved formulation of 224Ra-labeled calcium carbonate microparticles by surface layer encapsulation and addition of EDTMP","volume":"13","author":"Li","year":"2021","journal-title":"Pharmaceutics"},{"issue":"16","key":"10.1016\/j.jconrel.2025.113815_bb0470","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.7150\/thno.99782","article-title":"Targeted radiopharmaceuticals: an underexplored strategy for ovarian cancer","volume":"14","author":"Crabb\u00e9","year":"2024","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.jconrel.2025.113815_bb0475","doi-asserted-by":"crossref","first-page":"17348","DOI":"10.1021\/acsnano.1c05165","article-title":"Imaging strategy that achieves ultrahigh contrast by utilizing differential esterase activity in organs: application in early detection of pancreatic cancer","volume":"15","author":"Lee","year":"2021","journal-title":"ACS Nano"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925004353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925004353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:18:39Z","timestamp":1762269519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925004353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":95,"alternative-id":["S0168365925004353"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113815","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticles in nuclear medicine: From diagnostics to therapeutics","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113815"}}